New Market Study Published: Neurofibromatoses Type II - Pipeline Review, H2 2013
Global Markets Direct's, 'Neurofibromatoses Type II - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Neurofibromatoses Type II, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Neurofibromatoses Type II. Neurofibromatoses Type II - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites,...
View full press release